GLP-1 receptor agonists mimic glucagon-like peptide-1, a hormone that helps regulate blood sugar and appetite, leading to significant reductions in body weight for many people
Both HSA and FSA plans cover PlexusDx GLP-1 medications equally as qualified medical expenses
In contrast, weight loss magnitude during the pre-landmark period was not significantly associated with post-landmark all-cause mortality ( P = 0.14), the composite cardiovascular endpoint ( P = 0.55), incident cerebrovascular disease ( P = 0.25), incident heart failure ( P = 0.89), or incident valvular or rheumatic heart disease ( P = 0.43) (Fig
Clients benefit from a reduction in body weight, a lower body fat percentage, an improved energy level, and an increase in exercise tolerance
With 100 per pack, it is a cost-effective solution for regular injections